Article Details

Statera Biopharma Announces First Patient Dosed in Study of STAT-205 for Acute COVID

Retrieved on: 2021-12-20 21:12:28

Tags for this article:

Click the tags to see associated articles and topics

Statera Biopharma Announces First Patient Dosed in Study of STAT-205 for Acute COVID. View article details on hiswai:

Excerpt

20, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that ...

Article found on: sports.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up